Cannabis causes several adverse eye effects including reduced corneal cell density, impaired night vision, and retinal dysfunction, while short-term intraocular pressure reduction is insufficient for glaucoma treatment.
Cannabis users, ophthalmologists, glaucoma patients
IOP reduction too brief for glaucoma treatment
What the researchers found
Adverse ocular effects include eyelid tremor, ptosis, reduced corneal endothelial cell density, dry eyes, red eyes, and neuro-retinal dysfunction. Cannabis may transiently impair night vision, depth perception, and contrast sensitivity. THC reduces intraocular pressure short-term but insufficient for glaucoma. Potential therapeutic uses: treatment-refractory blepharospasm, dry eye, and MS-related nystagmus.
Why it matters
Cannabis users should be aware of potential visual effects, and clinicians should not recommend cannabis for glaucoma despite its intraocular pressure-lowering effect. The review clarifies what is and is not supported by evidence for ocular conditions.
The numbers in context
Estimated 219 million cannabis users globally. THC reduces intraocular pressure transiently. Impairments documented in night vision, depth perception, binocular and monocular contrast sensitivity, and dynamic visual acuity.
How the study worked
Narrative review of current literature on adverse effects and therapeutic applications of cannabis and cannabinoids on the eye.
What this study cannot tell us
Narrative review without systematic methodology. Most ocular effects documented in case reports or small studies. Dose-response relationships poorly characterized. Chronic vs. acute use effects not always distinguished.
How to read the evidence
Comprehensive narrative review covering diverse ocular effects, but based on heterogeneous and often small-scale evidence.
When this study was published
2024 narrative review of cannabis and eye health literature
The bigger picture
The persistent myth that cannabis treats glaucoma originated from short-term IOP studies, but the effect is too brief and inconsistent for clinical use. This review helps update public understanding while identifying genuinely promising ocular applications.
Questions still open
- Do corneal endothelial changes reverse after cannabis cessation? Could CBD-specific formulations provide ocular anti-inflammatory benefits without THC side effects?
Common questions
Can cannabis treat glaucoma?
Does cannabis affect vision?
Read the original research
Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review.
Clinical ophthalmology (Auckland, N.Z.), 18, 3529-3556
Citation
Bondok, Mostafa; Nguyen, Anne Xuan-Lan; Lando, Leonardo; Wu, Albert Y. (2024). Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review.. Clinical ophthalmology (Auckland, N.Z.), 18, 3529-3556. https://doi.org/10.2147/OPTH.S501494
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk